(A) Quantification of mitophagic flux using flow cytometry in cortical neurons (DIV11) treated with rapamycin (20nM, 24hr) or carbamazepine (100 µM, 24hr, n=3×106 recorded events per condition from 3–6 experiments).
(B) Recruitment of Venus-LC3 labeled autophagosomes to axonal mitochondria following acute Δ Ψm-depolarization with antimycin A (40 µM) in hippocampal neurons (DIV7/8) pretreated with rapamycin, carbamazepine or a combination of both drugs (n>35 axons per condition from 5–10 experiments).
(C&D) Western blotting for several proteins involved in mitophagy in cytosolic and mitochondria-enriched fractions from cortex of Tsc1cc;Syn1Cre+ mice (n=8), Tsc1CC;Syn1Cre+ mice treated with rapamycin (n=4), and Tsc1ww;Syn1Cre+ littermates (n=8, PND 21).
(E) Number of mitochondria per 100 µm axon in hippocampal neurons (DIV 7/8) pretreated with rapamycin or carbamazepine (n>20 axons per condition from >4 experiments).
(F) Number of mitochondria in callosal projection axons from Tsc1cc;Syn1Cre+ mice (n=2), Tsc1cc;Syn1Cre+ mice treated with rapamycin (n=3), and Tsc1ww;Syn1Cre+ littermate controls (n=3, PND 21) using transmission electron microscopy.
(G) Mitochondrial transport in the mid axon of hippocampal neurons (DIV7/8) pretreated with rapamycin or carbamazepine (n>15 axons per condition from 3–5 experiments).
(H) Number of stable presynaptic puncta per 100 µm axon and the percentage of stable presynaptic puncta supported by mitochondria in hippocampal neurons (DIV7/8) pretreated with rapamycin (20nM, 24hr), carbamazepine (100 µM, 24hr) or a combination of both drugs (n=14 axons per condition from 7 experiments).
(I) Dwell time of motile mitochondria at and outside of stable presynaptic puncta in hippocampal neurons (DIV7/8) pretreated with rapamycin, carbamazepine or a combination of both drugs (n=14 axons per condition from 7 experiments).
Cyto=cytosolic fraction, Mito=mitochondrial fraction, ns=not significant; *p<0.05, **p<0.01, ***p<0.001, ****<p.0001. See also Figure S6.